|
|
|
|
|
|
|
¾àÇ°°Ë»ö |
|
ºÎÀÛ¿ë ¹× ´ëó¹ý |
|
|
|
|
|
|
|
´Ù³ªÁ¨½Ç·Î½ºÅ¸Á¹¼¹æĸ½¶200mg Danagen Cilostazol SR Cap. 200mg
|
Àü¹®ÀǾàÇ° | ±Þ¿©
|
|
|
|
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
Èò»ö ¶Ç´Â ¿¬ÇÑ È²»öÀÇ °ú¸³À» Æ÷ÇÔÇÏ´Â »óÇÏ Èò»öÀÇ °æÁúĸ½¶Á¦ |
|
|
|
|
|
Á¦Á¶È¸»ç |
´ë¿ø¹ÙÀÌ¿ÀÅØÁÖ½Äȸ»ç
|
ÆǸÅȸ»ç |
´ë¿ø¹ÙÀÌ¿ÀÅØÁÖ½Äȸ»ç
|
Çã°¡Á¤º¸ |
Á¤»ó
(2019.11.05)
|
BIT ¾àÈ¿ºÐ·ù |
Ç×Ç÷Àü,Ç÷¼ÒÆÇÀÀÁý¾ïÁ¦Á¦ (Antithrombotics, Antiplatelet Agents)
|
º¹ÁöºÎºÐ·ù |
339[±âŸÀÇ Ç÷¾× ¹× ü¾×¿ë¾à ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
057600340 \889 ¿ø/1ĸ½¶(2024.07.01)(ÇöÀç¾à°¡)\889 ¿ø/1ĸ½¶(2023.09.05) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
cilostazol / B01AC23 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
¸ÞŸ¾ÆÅ©¸±»ê¡¤¸ÞŸ¾ÆÅ©¸±»ê¸ÞÆ¿°øÁßÇÕü(1:2),
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
½ÃÆ®¸£»ê,
¿¡Æ¿¼¿·ê·Î¿À½º,
Ä«¶ó±â³,
ĸ½¶,
Æú¸®¼Ò¸£º£ÀÌÆ®80
|
|
|
|
|
|
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-08-14 |
|
|
|
|
|
|
|
|
|